Acute myeloid leukemia (AML) with normal karyotype had a heterogenous prognosis. In this subgroup, FLT3-internal tandem duplication (ITD) was strongly associated with a poor prognosis. [1] [2] [3] Recently, it was reported that mutations of nucleophosmin (NPM) gene occur in 50-60% of adult AML with normal karyotype and were frequently associated with FLT3-ITD. In the AML patients with normal karyotype and FLT3-ITD, patients with NPM gene mutations showed a better prognosis than those without NPM gene mutations. [4] [5] [6] However, the frequency and clinical impact of NPM gene mutations in pediatric AML patients with normal karyotype remained uncertain because there were a few number of reports. 7, 8 We searched for NPM gene mutations in 33 (20.9%) of 158 patients with normal karyotype who were treated on Japanese Childhood AML Cooperative protocol, AML 99 (0-15 years old, median 8 years old). 9 We amplified exon 12 of NPM gene using the primers; NPM cDNA Fow, 5
0 -AAAGGTGGTTCTCTTCCC AAA-3 0 and NPM cDNA Rev, 5 0 -GCATTATAAAAAGGACAGCC AGA-3 0 and directly sequenced on a DNA sequencer (ABI 310; Applied Biosystems, Foster City, CA, USA) using a BigDye terminator cycle sequencing kit (Applied Biosystems). 9 We could not find any NPM gene mutations in this study.
It was reported that the frequency of NPM gene mutations in children (o18 years old) was very low (children 1 out of 47 (2.1%) versus adults 32 out of 126 (25.4%), Po0.001). 8 Furthermore, they suggested that NPM gene mutations were also rarely detected in patients younger than 40 years old (3 (3.5%) out of 85). On the other hand, it was reported that NPM mutations were found in seven (27.1%) of 26 pediatric AML patients with normal karyotype from Italy. 7 These seven patients ranged from 5.0-17.9 years old, 10 years old (n ¼ 2), 11 years old (n ¼ 2) and 5, 8, 17 years old (n ¼ 1). Notably, two AML patients with NPM gene mutations have been reported in adult Japanese AML study (15 and 16 years old). 5 We also analyzed FLT3-ITD and RAS gene alterations in these patients and found FLT3-ITD in nine (27.3%), NRAS mutation in two (6.1%) and KRAS mutation in three (9.1%). The frequencies of these gene alterations were compatible with those of previous reports. 2, 3 We considered that NPM gene mutations may be infrequent in Asian pediatric AML patients with normal karyotype, especially less than 15 years old. Frequency of NPM gene mutations depends on age and may depend on races. Further larger studies of NPM gene analysis are needed to clarify this item.
